Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
23 June 2024
| m 12:20 | Non-small cell lung cancer diffhist -35 Jwarner talk contribs | ||||
| m 12:19 | Non-small cell lung cancer - historical diffhist -1,605 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & Vadimezan | ||||
22 June 2024
| m 02:22 | Non-small cell lung cancer diffhist +131 Jwarner talk contribs →Cisplatin & Etoposide (EP) {{#subobject:gocg67|Regimen=1}} | ||||
18 June 2024
|
|
m 10:54 | Pembrolizumab (Keytruda) 2 changes history +220 [Jwarner (2×)] | |||
| m |
|
10:54 (cur | prev) -2 Jwarner talk contribs | |||
| m |
|
10:53 (cur | prev) +222 Jwarner talk contribs →Endometrial cancer | |||
15 June 2024
|
|
m 00:29 | Durvalumab (Imfinzi) 3 changes history +314 [Jwarner (3×)] | |||
| m |
|
00:29 (cur | prev) 0 Jwarner talk contribs | |||
| m |
|
00:27 (cur | prev) +53 Jwarner talk contribs | |||
| m |
|
00:25 (cur | prev) +261 Jwarner talk contribs →History of changes in FDA indication | |||
2 June 2024
1 June 2024
| m 04:03 | Nivolumab (Opdivo) diffhist +210 Jwarner talk contribs →Malignant pleural mesothelioma | ||||
| m 03:50 | Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →Renal cell carcinoma | ||||